Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Cash & Equivalents (2016 - 2025)

InfuSystem Holdings' Cash & Equivalents history spans 16 years, with the latest figure at $3.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 504.55% year-over-year to $3.2 million; the TTM value through Dec 2025 reached $3.2 million, up 504.55%, while the annual FY2025 figure was $3.2 million, 504.55% up from the prior year.
  • Cash & Equivalents reached $3.2 million in Q4 2025 per INFU's latest filing, up from $955000.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $3.2 million in Q4 2025 to a low of $134000.0 in Q2 2023.
  • Average Cash & Equivalents over 5 years is $677200.0, with a median of $337000.0 recorded in 2022.
  • The largest YoY upside for Cash & Equivalents was 805.25% in 2021 against a maximum downside of 98.07% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $186000.0 in 2021, then dropped by 11.29% to $165000.0 in 2022, then soared by 40.0% to $231000.0 in 2023, then surged by 128.14% to $527000.0 in 2024, then skyrocketed by 504.55% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for INFU's Cash & Equivalents are $3.2 million (Q4 2025), $955000.0 (Q3 2025), and $720000.0 (Q2 2025).